CONCLUSION:
Despite its infrequency, TTM can substantially have a negative impact on
mental status, life quality and psychosocial function, leading towards
patient behavioral aberrancies. Identifying any potential comorbidity is
essential to implement a thorough treatment plan. By identifying and
characterizing subgroups of individuals based on their unique clinical
features and comorbidities, we can gain more insight into the underlying
mechanisms of this condition and develop more refined biological,
genetic, and therapeutic studies. In this study, we present a patient
with a diagnosis of TTM and BN with ongoing adult onset of ADHD as well
as a history of MDD. Pharmacological treatments were planned and
prescribed according to existing comorbidities to approach the patient’s
clinical condition effectively. Current evidence also supports the use
of a multidisciplinary approach including dermatologists, psychiatrists,
counselors, and even family members to effectively support and treat the
expanding and diverse patient group presenting with TTM and its
multifaceted nature.